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Objectives This study was conceived to describe the evolution of aortic dimensions in patients with moderate post-stenotic
ascending aorta dilation (50 to 59 mm) submitted to aortic valve replacement (AVR) alone.
Background The appropriate treatment of post-stenotic ascending aorta dilation has been poorly investigated.
Methods Ninety-three patients affected by severe isolated calcific aortic valve stenosis in the tricuspid aortic valve accom-
panied by moderate dilation of the ascending aorta (50 to 59 mm) were submitted to AVR only. All patients
were followed for a mean of 14.7  4.8 years by means of periodic clinical evaluations and echocardiography
and tomography scans of the thorax.
Results Operative mortality was 1.0% (1 patient). During the follow-up, 16 patients died and 2 had to be reoperated for
valve dysfunction. No patients experienced acute aortic events (rupture, dissection, pseudoaneurysm), and no
patient had to be reoperated on the aorta. There was not a substantial increase in aortic dimensions: mean aor-
tic diameter was 57  11 mm at the end of the follow-up versus 56  02 mm pre-operatively (p  NS). The
mean ascending aorta expansion rate was 0.3  0.2 mm/year.
Conclusion In the absence of connective tissue disorders, AVR alone is sufficient to prevent further aortic expansion in pa-
tients with moderate post-stenotic dilation of the ascending aorta. Aortic replacement can probably be reserved
for patients with a long life expectancy. (J Am Coll Cardiol 2011;58:581–4) © 2011 by the American College
of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.03.040Aortic stenosis is becoming one of the most frequent
indications for surgery in the Western world, with enor-
mous clinical and economic implications (1,2); both the
industry and surgical communities are employing consider-
able resources to develop new methods of treatment of the
disease (3,4).
See page 585
Because aortic stenosis is accompanied in more than
one-half of patients by dilation of the ascending aorta
(which is currently not treatable by the new percutaneous
techniques), the definition of the optimal treatment of
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accepted March 17, 2011.post-stenotic dilation (ascending aorta replacement or not)
is an issue of major relevance. In this study, we report the
evolution of aortic dimensions in patients with moderate
post-stenotic ascending aorta dilation submitted to aortic
valve replacement (AVR) alone in the initial 15 years after
surgery.
Methods
Patients included in this study represent a consecutive
cohort of 93 patients operated in our institution from
January 1990 to December 2000. Based on pre-operative
echocardiography, all patients were affected by severe iso-
lated calcific stenosis of a tricuspid aortic valve accompanied
by dilation of the ascending aorta with a maximum diameter
between 50 and 59 mm.
The diagnosis of tricuspid aortic valve was always con-
firmed at surgery by visual inspection, as outlined in the
operative report. The criteria for the diagnosis of bicuspid or
tricuspid aortic valve were those initially described by
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bicuspid aortic valve and/or more
than slight aortic insufficiency
were considered absolute exclu-
sion criteria, and patients with
these features were submitted to
ascending aorta replacement. In
fact, during the study period, no
patient with tricuspid stenotic aortic valve, absence of
connective tissue disease, and dilated ascending aorta 60
mm was submitted to aortic surgery, whereas 381 patients
with bicuspid or insufficient aortic valve and aortic dilation
50 mm were submitted to ascending aorta replacement.
Seventy-three patients underwent pre-operative com-
puted tomography (CT) scan of the thorax; at the time of
the study, pre-operative CT scans were available for review
for 64 of these patients.
All patients were submitted to conventional AVR by full
median sternotomy and moderately hypothermic cardiopul-
monary bypass. No plication or replacement of the ascend-
ing aorta was performed.
After surgery, all surviving patients were submitted to
periodic (6 months after surgery and then every 12 months)
physical and echocardiographic examinations. Transtho-
racic echocardiography was performed at each follow-up
visit, whereas transesophageal examination or CT scan were
reserved for patients who needed a more in-depth evaluation.
For the purpose of the present study, all patients were
re-evaluated physically and by transthoracic echocardiogra-
phy. In the 64 patients for whom a pre-operative CT scan
was available, a follow-up contrast-enhanced CT scan of the
thorax was also performed.
In the cases of in-hospital death during the follow-up, all
medical and autopsy reports were reviewed for the cause of
death; for out-of-hospital fatalities the death certificate was
requested.
The mean duration of follow-up was 14.7  4.8 years.
ollow-up was 100% complete.
tatistical analysis. Continuous data are presented as
ean  SD and categorical variables as percentages. Inter-
group comparison (pre-treatment aortic diameter vs. aortic
diameter at the end of follow-up) was performed using the
Student t test for paired data. The statistical analysis was
conducted using SPSS version 13.0 for Windows (SPSS
Inc., Chicago, Illinois).
The ascending aortic expansion rate was calculated for
those individuals who demonstrated some degree of aortic
growth during the follow-up. Conversely, the average aortic
diameter at the end of follow-up was calculated in the entire
population, including those who demonstrated unchanged
aortic diameter at the end of the follow-up.
Results
Patient population. The pre-operative and intraoperative
Abbreviations
and Acronyms
AVR  aortic valve
replacement
CT  computed
tomographycharacteristics of the population are summarized in Table 1.he mean age was 67.1 years, with a male/female ratio of
.87; most of the patients were in New York Heart
ssociation functional class I or II, and only a few had a
oor left ventricular ejection fraction. Hypertension, periph-
ral vasculopathy, and chronic pulmonary disease were the
ost frequent comorbidities. The mean pre-operative aortic
iameter was 56  2 mm.
In-hospital data. The mean cardiopulmonary bypass and
cross-clamp times were 54 and 66 min, respectively. In 71
patients, we implanted a mechanical prosthesis, whereas a
stented porcine bioprosthesis was used in the remaining 22
patients. This is because we favor the use of mechanical
prostheses and reserve biological valves for very old patients
or patients with clear contraindications to lifetime antico-
agulation. Most of the implanted prostheses were in the 19
to 23 mm range, with very few 25 mm.
Operative mortality was 1.0% (n  1) and was related to
a massive perioperative stroke. Other major complications,
as well as details of the early post-operative course of the
patients, are summarized in Table 2.
Follow-up data. The mean duration of follow-up was 14.7 
4.8 years. During this period, 16 patients died (17.3%); 11
of these deaths occurred in-hospital. Causes of deaths are
detailed in Table 3. Nine of the 16 follow-up deaths (7 of
the patients who died from cardiovascular cases) were
submitted to autopsy. In no cases was death attributed to an
aortic event.
One patient had to be reoperated for endocarditis 69
months after the initial surgery; he died on the 42nd
operative day owing to uncontrollable sepsis. Another pa-
tient was successfully reoperated for valve thrombosis 113
months after the initial operation. Three patients were
submitted to coronary artery bypass surgery and 4 to
percutaneous coronary interventions. No patients experi-
enced acute aortic events (rupture, dissection, pseudoaneu-
Pre-Operative and Intraoperative DataTable 1 Pre-Operative and Intraoperative Data
Age, yrs 67.1 5.3
Sex, male/female 69/24
NYHA functional class I–II 79
NYHA functional class III–IV 14
Hypertension 44
Chronic pulmonary disease 11
Peripheral vasculopathy 9
Previous stroke 6
Serum creatinine 200 mol/l 5
LVEF 0.30 4
Mean pre-operative aortic diameter, mm 56 2
Mean cross-clamp time, min 54 11
Mean CPB time, min 66 16
Type of prosthesis
Mechanical 71
Biological 22
Values are mean  SD or n.
CPB  cardiopulmonary bypass; LVEF  left ventricular ejection fraction; NYHA  New York
Heart Association.
p
e
s
d
s
a
w
w
a
D
T
d
a
m
a
p
h
a
t
a
i
l
p
a
d
s
o
m
9
(
p
m
I
p
c
c
583JACC Vol. 58, No. 6, 2011 Gaudino et al.
August 2, 2011:581–4 Evolution of Post-Stenotic Aortic Dilationrysm) during the follow-up, and no patient had to be
reoperated for thoracic aortic pathology.
There was not a substantial increase in aortic dimensions
during the 10 years after surgery: the mean aortic diameter
was 57 11 mm at the end of the follow-up vs. 56 2 mm
re-operatively (p  NS). The mean ascending aorta
xpansion rate was 0.3  0.2 mm/year. No statistically
ignificant association was found between ascending aorta
ilation and any of the clinical variables examined. Figure 1
hows the frequency distribution of absolute change in
scending aorta diameter during the follow-up period,
hereas Figure 2 details the modifications of aortic diameter
ith time in patients for whom pre-operative CT scans were
vailable.
iscussion
he approach to patients with moderate post-stenotic
ilation of the ascending aorta remains controversial.
In patients with connective tissue disorder or bicuspid
ortic valve, the intrinsic disease of the vascular media
andates ascending aorta replacement. However, when
ortic dilation is the consequence of the modified flow
atterns through the stenotic valve and the vascular wall
istology is normal, it is assumed that valve replacement
lone can interrupt the process; in these cases, the oppor-
unity of adding aortic replacement surgery is questionable.
Because the prevalence of ascending aorta dilation in
ssociation with aortic valve disease is estimated at approx-
Intraoperative and Early Post-Operative ResultsTable 2 Intraoperative and Early Post-Operative Results
Operative deaths 1
MACCE (overall) 3
Acute myocardial infarction 2
Cerebrovascular accident 1
Revision for bleeding 3
Need for dialysis 1
Respiratory failure 1
Mean ICU length of stay, days 2.0 1.1
Mean post-operative stay, days 5.2 1.9
ICU  intensive care unit; MACCE  major adverse cardiocirculatory events.
Causes of Follow-Up DeathsTable 3 Causes of Follow-Up Deaths
Cardiovascular
Heart failure 2
Arrhythmias 1
Myocardial infarction 3
Stroke 2
Endocarditis 1
Rupture of abdominal aortic aneurysm 1
Noncardiovascular
Cancer 2
Accident 2
Dementia 1Suicide 1mately 60% of the total (although the moderate degree is
ess frequent), the impact of this controversy on clinical
ractice is of major relevance (6–8).
In the literature, only a few studies have specifically
nalyzed the evolution of untreated post-stenotic aortic
ilation in patients without connective tissue disorders
ubmitted to isolated AVR. Andrus et al. (6), reporting
n 107 patients with an aortic diameter 3.5 cm, found
no evidence of further dilation in the first 3 years after
isolated AVR. In the same year, Yasuda et al. (9) reported
a mean ascending aorta expansion rate of 0.08  0.08
m/m2/year in a small series of 14 patients followed for
.7 years after surgery. More recently, Botzenhardt et al.
10) described a reduction of the aortic diameter in 10
atients with pre-operative ascending aorta 4 cm at a
ean follow-up of 4.8 years after isolated valve surgery.
n the other series, bicuspid and tricuspid valves and
atients with slight and moderate dilation are usually
onsidered together, not allowing meaningful clinical
onclusions.
Figure 1 Frequency Distribution of Change in
Ascending Aorta Diameter During Follow-Up
In the great majority of cases, the mean aortic diameter
did not change during the long-term follow-up.
Figure 2 Modifications of Aortic Diameter During the Follow-Up
in Patients Submitted to Serial CT Scan Controls
In the subset of patients submitted to serial CT (computed tomography) con-
trols, the post-operative aortic diameter remained stable in the years after sur-
gery. FU  follow-up.
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Evolution of Post-Stenotic Aortic Dilation August 2, 2011:581–4The present report is to date the largest series of patients
with moderate post-stenotic aortic dilation submitted to
valve replacement alone and followed for almost 10 years.
The fact that none of our patients experienced acute
aortic events or had to be reoperated for thoracic aortic
disease is worthy of consideration. Concordantly, CT scans
and echocardiographic evaluations showed that there was
not a substantial increase in aortic dimensions during the 10
years after surgery, with a mean ascending aorta expansion rate
of 0.3  0.2 mm/year. These data suggest that once the
emodynamic derangement has been corrected by replace-
ent of the stenotic valve in these patients, the aortic wall
emained stable and no further dilation occurred.
The researchers who have evaluated the natural history of
ost-stenotic ascending aorta dilation in the absence of
alvular surgery have reported mean growth rates almost 10
imes faster than that described in our series (11,12).
oreover, the accepted expansion rate of aortic aneurysms
s by far higher than that reported in our patients (1.0
m/year vs. 0.3 mm/year) (12–14). All of these observa-
ions support the concept that atherosclerotic or degenera-
ive aneurysms and post-stenotic dilations have a different
hysiopathology: the first are derived from a derangement of
he aortic wall, and the hemodynamic effect of the valvular
tenosis is the cause of the dilatation in the latter. This
hysiopathological difference has obvious therapeutic impli-
ations: if aortic replacement is mandatory in the first type
f aneurysms, correction of the pathological flow patterns by
alve replacement alone is sufficient to prevent further aortic
xpansion in cases of post-stenotic dilations.
Although our study is a case series, it must be considered
hat all data were prospectively collected and that our
ollow-up was 100% complete. Moreover, all of the patients
or whom pre-operative CT scans were available underwent
ontrol CT scans of the thorax. In addition, the number of
atients is the largest reported and the follow-up the longest
n the literature. All of these considerations maximize the
ffordability of our observations, although further investiga-
ion on this issue is necessary to confirm our findings.
We are aware of the fact that our data contradict the
ublished guidelines for the treatment of diseases of the
scending aorta. However, it must be noted that these guide-
ines do not make specific recommendations for the different
ubtypes of aortic dilations, although it seems likely that the
hysiopathology, natural history, and treatment can be differ-
nt between degenerative or atherosclerotic and post-stenotic
neurysms.
onclusions
n the absence of connective tissue disorders or bicuspidy,
alve replacement alone is sufficient to prevent further aorticexpansion in patients with moderate post-stenotic dilation
of the ascending aorta. Ascending aorta replacement should
be considered only for very young patients with extremely
long life expectancy. Further studies are necessary to develop
specific therapeutic guidelines for the different types of
ascending aorta aneurysms.
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